About
Nurami Medical is a medical device company based in Haifa, Israel, founded in 2014 by Nora Nseir Manassa and Dr. Amir Bahar. The company specializes in developing advanced surgical products for soft tissue repair and regeneration, utilizing nanotechnology and innovative biomaterials. Their flagship product, ArtiFascia®, is the first multilayer dural substitute designed to enhance outcomes in soft tissue repair, particularly after neurosurgery. This product is based on a proprietary electrospun nanofiber platform that creates bioresorbable polymer scaffolds, mimicking the natural extracellular matrix to accelerate tissue healing and minimize complications. Nurami Medical's offerings include surgical sealants and grafts that promote safe healing and healthy tissue formation. The company is actively involved in clinical trials to validate the safety and efficacy of ArtiFascia® and aims to obtain FDA and CE regulatory clearances. With a team of experts in various fields, Nurami Medical is committed to advancing medical innovation and improving patient outcomes globally.
Technologies
Keywords
Company Information
-
Employees 31
-
Founded 2014
-
Annual Revenue $8000000
-
Total Funding $39377909
Location
Haifa, Haifa District, Israel, 30000